ABSTRACT & COMMENTARY

Is RhoGAM Needed for Rh-Negative Women Experiencing First-Trimester Pregnancy Loss or Induced Abortion?

Name: Relias Media
Price range: $

July 1, 2020

In this prospective cohort pilot study, the authors validated a flow cytometry protocol for detecting fetal red blood cells and determined that fetal red blood cell exposure in first-trimester uterine aspiration was well below the calculated threshold for maternal Rh sensitization.

Issue Date: July 1, 2020

Table of Contents

Financial Disclosure: OB/GYN Clinical Alert’s Editor Rebecca H. Allen, MD, MPH, reports that she receives grant/research support from
Bayer, and is a consultant for Bayer, Mylan, and Merck. Peer Reviewer Catherine Leclair, MD; Nurse Planner Andrea O’Donnell, FNP;
Editorial Group Manager Leslie Coplin; Editor Jason Schneider; Executive Editor Shelly Mark; and Accreditations Director Amy M.
Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements